Effective Date: February 5, 2021
Galectin Therapeutics Inc. (“Galectin Therapeutics” or the “Company”) provides the materials on this website for general information and educational purposes. This website contains information concerning the Galectin Therapeutics NAVIGATE Study clinical trial of belapectin for the prevention of esophageal varices in NASH cirrhosis (NCT04365868) which may be useful to potential patients with NASH cirrhosis, physicians treating patients with NASH cirrhosis, our collaborators and trial investigators, as well as the general public.
This site is intended for educational and informational purposes only and should not be considered a program for patient recruitment or patient enrollment in the trial. Patients considering participation in the trial should discuss their possible participation with their physicians.
Please read the following Terms and Conditions carefully. These Terms and Conditions (the “Terms”) apply to your access to, and use of, this website. By accessing, viewing or using this website, you agree to be bound by these Terms and Conditions. If you do not agree to be bound by these Terms and Conditions, you must stop accessing or using this website. We reserve the right to revise any or all of these Terms and Conditions, at any time and without notice, by posting the updated terms. Your use of this website is subject to any such revisions, and you should periodically visit this page to review the current Terms and Conditions which are applicable to your use of our website.
Galectin Therapeutics makes no representations or warranties and assumes no liability as to the accuracy, completeness, reliability or usefulness of any information contained on this website. Further, Galectin Therapeutics expressly disclaims any obligation to update or correct information contained on this website and explicitly disclaims any duty to do so. Galectin Therapeutics assumes no liability or responsibility for any errors or omissions in the content of this website. We reserve the right to change or modify the information or materials on this website at any time and in any way, without notice.
Nothing on this website constitutes or is intended to constitute an invitation or offer to invest or deal in the securities of Galectin Therapeutics.
Subject to your compliance with the Terms, Galectin Therapeutics grants you a limited non-exclusive, non-transferable, non-assignable and non-sublicensable license to access and use the Website for your own personal use only, and not for use for any business purpose or commercial activity. This license is granted for the sole purpose of enabling you to use and enjoy the benefit of the Website as provided by Galectin, in the manner permitted by the Terms.
This website contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements express our expectations or predictions of future events or results. They are not guarantees and are subject to many risks and uncertainties. There are a number of factors – many beyond our control – that could cause actual events or results to be significantly different from those described in the forward-looking statement. Any or all of the Company’s forward-looking statements in this website, its reports or in any other public statements the Company makes may turn out to be wrong. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” or words of similar meaning. They may also use words such as “will,” “would,” “should,” “could,” or “may.” The actual results of the Company or the NAVIGATE Study could differ materially from the results contemplated by these forward-looking statements. Among the factors that could cause actual results to differ materially are uncertainties as to whether the objectives in the NAVIGATE Study can be achieved, whether belapectin has the therapeutic result that is desired, and whether NAVIGATE Study will lead ultimately to regulatory approval of this drug candidate.
These and other risks and uncertainties that could affect our actual results are discussed in greater detail in the Company’s recent filings with the Securities and Exchange Commission, including its reports on Form 8-K, 10-Q and 10-K. For a discussion of additional factors impacting our business, please see the Company’s most recent Annual Report on Form 10-K and our subsequent filings with the SEC.
The Company does not assume responsibility for the accuracy or completeness of these forward-looking statements. Furthermore, we do not undertake any duty to update any forward-looking statements or to publicly announce any revisions that we may make.
LINKS TO THIS WEBSITE AND USE OF OUR MARKS. You are hereby granted a non-exclusive, limited, and revocable license to link to this website. We reserve the right to revoke this license generally, or your right to use specific links, at any time. If we revoke this license, you agree to remove and disable any and all of your links to this website immediately.
You agree not to present the link to this website in such a way that it is associated with advertising or appears to be an endorsement of any organization, product, or service. You agree that the link will not appear on a website that a reasonable person may consider obscene, defamatory, harassing, grossly offensive, or malicious. Under no circumstances may you “frame” this website or any of its content or copy portions of this website to a server. You agree not to display or use our logos or trademarks in any manner without our prior written permission.
Any time you access or use the Website, you are required to comply with our User Conduct Guidelines, as set forth below. You may not:
All contents of this website are protected by copyright and/or other intellectual property rights, and may not be modified, distributed, posted or transmitted without our prior written consent. You may download material from our website for your own personal, non-commercial use only. No copyright notices, other intellectual property or legal notices or other identifying information may be removed from downloaded materials. You may not download material from our website for any other purpose without our prior written consent.
Galectin Therapeutics and its associated logo is a registered trademark of Galectin Therapeutics Inc. The logo for the NAVIGATE Study is a trademark of Galectin Therapeutics Inc. Belapectin is the USAN assigned name for Galectin Therapeutics’ galectin-3 inhibitor GR-MD-02. All registered trademarks and other trademarks are property of their respective owners.
All trademarks and product names are the property of their respective owners. Nothing contained in our website should be construed as granting any license or right to use any trademarks or logos.
Galectin Therapeutics assumes no liability for the accuracy, completeness, currency or reliability of the information on this website. Any animations contained in this website are artist renderings of the mechanism of action as we understand it. Galectin Therapeutics maintains the right to update the materials of this website at any time, without notice. Moreover, Galectin Therapeutics shall not be responsible for website errors due to mechanical, technical or functional failure. Galectin Therapeutics maintains this website from within the United States and is not liable for representation of materials and information outside of the United States.
THE CONTENT ON THE GALECTIN THERAPEUTICS WEBSITE IS PROVIDED “AS IS” AND “AS AVAILABLE,” AND GALECTIN THERAPEUTICS MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, CREATED BY LAW, CONTRACT OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE OR NON-INFRINGEMENT. GALECTIN THERAPEUTICS MAKES NO REPRESENTATION OR WARRANTY THAT ACCESS TO THE WEBSITE WILL BE AVAILABLE ON A CONTINUOUS BASIS, WILL BE UNINTERRUPTED, OR THAT THE INFORMATION CONTAINED ON THE WEBSITE WILL BE TIMELY, COMPLETE OR ERROR FREE. EACH USER ASSUMES FULL RESPONSIBILITY AND ALL RISKS ARISING FROM ACCESS TO AND USE OF THIS WEBSITE.
Some jurisdictions do not allow the exclusion of implied warranties, so the above exclusion may not apply to you.
We do not warrant that the functions or information contained in or accessed through this website are free of computer viruses or other harmful components. Galectin Therapeutics assumes no responsibility or liability for any error, defamation, libel, slander, omission, falsehood, or inaccuracy contained in any information within this website or accessed through this website.
BY USING THIS WEBSITE, YOU AGREE THAT WE ARE NOT AND THAT NO PERSON OR COMPANY ASSOCIATED WITH US SHALL BE LIABLE FOR ANY DAMAGE RESULTING FROM YOUR USE OR INABILITY TO USE THIS WEBSITE OR THE MATERIALS ON THIS WEBSITE. THIS PROTECTION COVERS CLAIMS BASED ON WARRANTY, CONTRACT, TORT, STRICT LIABILITY, AND ANY OTHER LEGAL THEORY. THIS PROTECTION COVERS US, OUR OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS MENTIONED ON THIS WEBSITE. THIS PROTECTION COVERS ALL LOSSES INCLUDING, WITHOUT LIMITATION, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY, AND PUNITIVE DAMAGES, PERSONAL INJURY/WRONGFUL DEATH, LOST PROFITS, OR DAMAGES RESULTING FROM LOST DATA OR BUSINESS INTERRUPTION.
GALECTIN’S AGGREGATE LIABILITY ARISING OUT OF OR IN CONNECTION WITH THESE TERMS SHALL BE LIMITED TO ONE HUNDRED U.S. DOLLARS (US$100).
Some jurisdictions do not allow the limitation of liability described above, so the above limitation may not apply to you and our liability will be limited to the maximum extent permitted by law.
Should you view a Galectin Therapeutics published document and respond with information including: feedback data, questions, comments, suggestions, or the like, regarding the content of any such Galectin Therapeutics document, such information shall be deemed to be non-confidential and Galectin Therapeutics shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose and distribute the information to others without limitation. Galectin Therapeutics shall be free to use any ideas, concepts, know-how or techniques contained in such information for any purpose whatsoever including but not limited to developing, manufacturing and marketing products incorporating such information. If you transmit any ideas, information, concepts, know-how or techniques or materials to us through this website, you hereby irrevocably transfer and assign to Galectin all of your right, title, and interest in and to all such information and feedback, including all worldwide patent, copyright, trade secret, moral and other proprietary or intellectual property rights therein, and waive any moral rights you may have in such information and feedback.
This website may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for advice provided by a doctor or other qualified healthcare professional. You should not use this information for diagnosing a health or fitness problem or disease. You should always consult with a doctor or other healthcare professional.
Although the information on this website is accessible to users outside of the U.S., the information on the website pertaining to Galectin Therapeutics products is intended for use only by residents of the U.S. Other countries may have laws, regulatory requirements and medical practices that differ from those in the U.S. Galectin Therapeutics reserves the right to limit provision of our products or services to any person, geographic region or jurisdiction and/or to limit the quantities or any products or services we provide. If you choose to access the website from a location outside the United States, you do so at your own risk and you are solely responsible for compliance with applicable laws, rules and regulations, including export laws and any regulations and local laws regarding online conduct and content.
If any of these Terms or Conditions shall be deemed to be invalid, void, illegal or for any reason unenforceable, that Term or Condition shall be deemed severable and shall not affect the validity and enforceability of the remaining terms and conditions.
Our failure to exercise any right or enforce any obligation under these Terms or to take action with respect to a breach by you or others will not constitute a waiver of such right, obligation or breach. The waiver of any right, obligation or breach will be effective only if in writing and signed by a duly authorized representative of Galectin. In addition, no waiver granted in any instance shall constitute a waiver in any other instance.
Except as expressly set forth in the Terms, the exercise by either party of any of its remedies under the Terms will be without prejudice to its other remedies available under contract, at law, in equity, or otherwise.
If you have any questions or concerns, please contact Galectin at email@example.com.
You can also write to us at:
Galectin Therapeutics Inc.
4960 Peachtree Industrial Boulevard
Norcross, Georgia 30071
Pursuant to California Civil Code §1789.3, California residents are also entitled to the following specific consumer rights notice:
Complaints regarding the website or requests to receive further information regarding use of the website may be sent to the above address or to firstname.lastname@example.org.
The Complaint Assistance Unit of the Division of Consumer Services of the California Department of Consumer Affairs may be contacted in writing at 1625 North Market Boulevard, Suite N112, Sacramento, CA 95834 or by telephone at (916) 445-1245 or (800) 952-5210. Hearing impaired persons may call TDD (800)-326-2297 or TDD (916)-928-1227, see www.dca.ca.gov for additional information.